Skip to main content
Mallory
High

Authenticated Privilege Escalation in Ivanti Neurons for ITSM

IdentifiersCVE-2026-9614CWE-284· Improper Access Control

CVE-2026-9614 is a high-severity improper access control vulnerability in Ivanti Neurons for ITSM affecting both cloud and on-premises deployments. The issue allows a remote attacker with valid low-privilege credentials to escalate privileges and obtain administrator-level access without user interaction. Publicly available context attributes the flaw to improper access control within the platform core, but does not identify a specific vulnerable function or code path. Affected versions include Ivanti Neurons for ITSM (On-Premises) 2025.4 and prior, and Ivanti Neurons for ITSM (Cloud) 2026.1 and prior.

Share:
For your environment

Are you exposed to this one?

Mallory correlates every CVE against your assets, your vendors, and active adversary campaigns. Know which vulnerabilities matter for you, not just which ones are loud.

ANALYST BRIEF

Impact, mitigation & remediation

What it means. What to do now. Patch path, mitigations, and the assume-compromise checklist.

Impact

What an attacker gets, and what they’ve been doing with it.

Successful exploitation results in authenticated privilege escalation to full administrative access in Ivanti Neurons for ITSM. Given the product’s role in IT service management workflows, administrator compromise can expose sensitive organizational data, permit modification of user roles and permissions, alter system configuration and automation, and affect confidentiality, integrity, and availability. The provided CVSS v3.1 vector AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H and score of 8.8 indicate network-reachable exploitation with low attack complexity, requiring only low privileges and no user interaction, with high impact across all three CIA dimensions.

Mitigation

If you can’t patch tonight, do this now.

Where immediate patching is not possible, review and tighten role-based access controls and administrative role assignments to ensure permissions are limited to intended administrators only. Ivanti specifically recommended auditing role configurations because misconfigurations may increase exposure and make privilege escalation easier. Prioritize reducing unnecessary low-privilege accounts, validating delegated permissions, and monitoring for unauthorized role or privilege changes until fixed versions are deployed.

Remediation

Patch, then assume compromise.

For on-premises deployments, upgrade to a fixed release. Ivanti identified the following resolved on-premises versions: 2025.4 Patch 1, 2025.3 Patch 1, and 2025.2 Patch 1. Ivanti instructed customers to obtain updates through the Ivanti License System / License Server download portal and to patch immediately. For cloud deployments, Ivanti stated that fixes were already applied across customer environments in releases 2026.1 Patch 9 and 2026.2 Patch 1 on May 24 and 25, 2026; SaaS customers generally require no additional action for the vulnerability itself.
PUBLIC EXPLOITS

Exploits

No public exploits tracked yet. Mallory keeps watching.

VALID 0 / 0 TOTALView more in app

No public exploit code observed for this vulnerability.

EXPOSURE SURFACE

Affected products & vendors

Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.

VendorProductType
IvantiNeurons For Itsmapplication

Vendor-confirmed product mapping. Mallory continuously reconciles this list against your asset inventory.

What this page doesn’t show

The version that knows your environment.

This page is what’s public. Mallory adds the parts that aren’t: which of your assets are affected, which adversaries are exploiting it right now, which detections to deploy, and what to do tonight.
Exposure mapping

Query your assets running an affected version, and investigate the blast radius.

Threat actor evidence

Every observed campaign linking this CVE to a named adversary.

Associated malware

Malware families riding this exploit, with evidence and IOCs.

Detection signatures

YARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.

Vendor-by-vendor mapping

Cross-references every affected SKU, including bundled OEM variants.

Social activity14

Community discussion across Reddit, Mastodon, and other social sources.